Literature DB >> 23542016

Hepatitis B virus core protein enhances human telomerase reverse transcriptase expression and hepatocellular carcinoma cell proliferation in a c-Ets2-dependent manner.

Xiaoxiao Gai1, Peiqing Zhao, Yingfang Pan, Haixia Shan, Xuetian Yue, Juan Du, Zhenyu Zhang, Peng Liu, Hongxin Ma, Min Guo, Xiaoyun Yang, Wensheng Sun, Lifen Gao, Chunhong Ma, Xiaohong Liang.   

Abstract

Hepatitis B virus core protein can regulate viral replication and host gene expression. However, it is unclear whether and how hepatitis B virus core protein regulates hepatocellular carcinoma cell proliferation. Induction of hepatitis B virus core protein over-expression significantly enhanced the proliferation of hepatocellular carcinoma cells, while knockdown of hepatitis B virus core protein expression inhibited the proliferation of hepatocellular carcinoma cells. Altered hepatitis B virus core protein expression significantly changed the growth of implanted hepatocellular carcinoma in vivo. Microarray analysis indicated that hepatitis B virus core protein up-regulated human telomerase reverse transcriptase expression, which was further validated by over-expression and knockdown assays in vitro. Furthermore, knockdown of human telomerase reverse transcriptase expression mitigated the hepatitis B virus core protein-enhanced hepatocellular carcinoma cell proliferation and clone formation in vitro. Luciferase assays indicated that hepatitis B virus core protein enhanced the promoter activity of human telomerase reverse transcriptase, which was dependent on the binding of c-Ets2 to the promoter region between -192 and -187. In addition, hepatitis B virus core protein enhanced human telomerase reverse transcriptase transcription in HepG2 cells, but not in the c-Ets2-silencing HepG2 cells. Moreover, hepatitis B virus core protein promoted c-Ets2 nuclear translocation. Finally, significantly higher levels of human telomerase reverse transcriptase expression and nuclear c-Ets2 accumulation were detected in hepatitis B virus core protein-positive hepatocellular carcinoma samples. Our findings demonstrate that hepatitis B virus core protein promotes hepatocellular carcinoma cell proliferation by up-regulating the c-Ets2-dependent expression of human telomerase reverse transcriptase.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23542016     DOI: 10.1016/j.biocel.2013.03.015

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  6 in total

1.  Hepatitis B virus core antigen mutations predict post-operative prognosis of patients with primary hepatocellular carcinoma.

Authors:  Jian'an Jia; Huiming Li; Hui Wang; Shipeng Chen; Mengmeng Wang; Huijuan Feng; Yuzhen Gao; Yunjiu Wang; Meng Fang; Chunfang Gao
Journal:  J Gen Virol       Date:  2017-06-22       Impact factor: 3.891

2.  CUL4A facilitates hepatocarcinogenesis by promoting cell cycle progression and epithelial-mesenchymal transition.

Authors:  Yingfang Pan; Bo Wang; Xiaoyun Yang; Fuxiang Bai; Qun Xu; Xueen Li; Lifen Gao; Chunhong Ma; Xiaohong Liang
Journal:  Sci Rep       Date:  2015-11-23       Impact factor: 4.379

3.  The Matching Status Between Donor and Recipient Hepatitis B Seroepidemiology Makes a Difference in Liver Transplantation for Hepatocellular Carcinoma.

Authors:  Di Lu; Fan Yang; Jianyong Zhuo; Modan Yang; Zuyuan Lin; Pingbo Jin; Xuechun Cai; Beini Cen; Jianguo Wang; Xuyong Wei; Shusen Zheng; Xiao Xu
Journal:  Clin Transl Gastroenterol       Date:  2020-05       Impact factor: 4.396

4.  Hepatitis B Virus Core Protein Mediates the Upregulation of C5α Receptor 1 via NF-κB Pathway to Facilitate the Growth and Migration of Hepatoma Cells.

Authors:  Fanyun Kong; Yukai Tao; Dongchen Yuan; Ning Zhang; Qi Li; Tong Yu; Xiaoying Yang; Delong Kong; Xiaohui Ding; Xiangye Liu; Hongjuan You; Kuiyang Zheng; Renxian Tang
Journal:  Cancer Res Treat       Date:  2020-11-16       Impact factor: 4.679

5.  Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma.

Authors:  Xiao-Cui Wei; Ya-Ru Xia; Ping Zhou; Xing Xue; Shuang Ding; Li-Juan Liu; Fan Zhu
Journal:  World J Gastroenterol       Date:  2021-12-28       Impact factor: 5.742

Review 6.  A Pleiotropic Role of the Hepatitis B Virus Core Protein in Hepatocarcinogenesis.

Authors:  Caroline Lefeuvre; Hélène Le Guillou-Guillemette; Alexandra Ducancelle
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.